A Putative Hsa-miR-582-5p–CD81 Relationship Identified by Integrative Transcriptomic Analysis in Osteosarcoma
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031558 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ju-Fang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Osteosarcoma, MicroRNAs, Bone Neoplasms, Tetraspanin 28. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Technology of Taiwan, Ministry of Science and Technology of Taiwan.
Abstract (Originalsprache)
Osteosarcoma (OS) is the most common primary malignant bone tumor in adolescents, and outcomes for metastatic disease have remained poor, highlighting the need for molecular biomarkers. We integrated three Gene Expression Omnibus (GEO) mRNA expression datasets (GSE12865, GSE14359, and GSE246405) to identify differentially expressed genes (DEGs) between OS and non-malignant bone-related controls. Overlapping DEGs were used to build a protein–protein interaction network, and hub genes were prioritized using multiple network topology algorithms. Prognostic associations were evaluated using the R2 Genomics Platform. Putative upstream miRNAs targeting the top candidate were obtained from prediction databases and intersected with dysregulated circulating miRNAs from GSE65071 (localized OS plasma vs. healthy controls). Functional enrichment analyses (Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and cancer hallmarks) were performed to contextualize the candidate signature. We identified 107 overlapping DEGs and prioritized eight hub genes. CD81 was significantly associated with overall survival (Bonferroni-adjusted p = 0.043) and showed reduced expression in OS tissues and cell line models. hsa-miR-582-5p was nominated as a candidate miRNA predicted to target CD81 and was upregulated in OS plasma. Enrichment results linked the signature to angiogenesis, extracellular matrix remodeling, focal adhesion, and metastasis-associated signatures. These findings support CD81 as a candidate prognostic biomarker and nominate a putative hsa-miR-582-5p–CD81 relationship for future validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan.
- Translational Medicine Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan.
- Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan.
- School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan.
- School of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
- Division of Pediatric Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan.
ORCID-Profile: Peng Chen, Ying-Sui Sun
Förderung
- The Ministry of Science and Technology of Taiwan
- Ministry of Science and Technology of Taiwan
Zitieren
APA
Liu, J. F., Chang, T. M., Chang, C. J., Chen, P., & Sun, Y. S. (2026). A Putative Hsa-miR-582-5p–CD81 Relationship Identified by Integrative Transcriptomic Analysis in Osteosarcoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031558
Vancouver
Liu JF, Chang TM, Chang CJ, Chen P, Sun YS. A Putative Hsa-miR-582-5p–CD81 Relationship Identified by Integrative Transcriptomic Analysis in Osteosarcoma. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031558
BibTeX
@article{Liu2026,
author = {Liu, Ju-Fang and Chang, Tsung-Ming and Chang, Chi-Jen and Chen, Peng and Sun, Ying-Sui},
title = {A Putative Hsa-miR-582-5p–CD81 Relationship Identified by Integrative Transcriptomic Analysis in Osteosarcoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031558}
}
EUVIMED